Multi-omics Multi-specimens Evaluation of Oral-gut-systemic Profiles in Patients With Stage III-IV Periodontitis Pre- and After-therapy

Status: Recruiting
Location: See location...
Intervention Type: Procedure
Study Type: Interventional
Study Phase: Not Applicable
SUMMARY

Periodontitis is a chronic inflammatory disease of the tooth supporting structures induced by a dysbiosis in the oral and subgingival microenvironment of susceptible patients. The long-term swallowing of high doses of periodontal pathogenic microorganisms could induce a dysbiosis of the intestinal microbiota, favouring the establishment of an 'inflamed' microbiome in terms of composition and/or function. The present project is aimed at a better understanding of the etiopathogenetic correlation between periodontitis and intestinal dysbiosis, and aims to explore the hypothesis that periodontal treatment may influence the multi-omics profile on the oral-gut-systemic axis. 70 patients affected by stage III-IV periodontitis will be recruited, and treated by means of full-mouth scaling and root planing. Salivary, subgingival plaque, plasma and stool samples, together with a complete periodontal charting and a food diary will be collected and compared at baseline and after treatment. Age, gender and BMI-matched healthy individuals will be recruited as controls.

Eligibility
Participation Requirements
Sex: All
Minimum Age: 18
Healthy Volunteers: t
View:

• periodontitis Stage III or IV

• BMI between 20 and 29 kg/m2

• free diet

• presence of at least 20 teeth

Locations
Other Locations
Italy
CIR Dental School
RECRUITING
Turin
Contact Information
Primary
Mario Aimetti, PA
mario.aimetti@unito.it
+390116331541
Time Frame
Start Date: 2024-02-15
Estimated Completion Date: 2026-02-15
Participants
Target number of participants: 70
Treatments
Experimental: Conventional periodontal treatment
Periodontal treatment of stage III-IV periodontitis patients according to the guideline recommendation from the European Federation of Periodontology will be provided.
Related Therapeutic Areas
Sponsors
Leads: University of Turin, Italy

This content was sourced from clinicaltrials.gov